Start-Up Spotlight: CorWave Takes Inspiration From Nature To Tackle Heart Failure
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
You may also be interested in...
Patient selection criteria will be the key to allowing CMS coverage of left ventricular assist devices (LVADs) when there is no longer a coverage with evidence development requirement, the US agency wrote.
The expanded labeling gives Medtronic's HVAD, acquired when it bought HeartWare last summer, the same indication as Abbott's HeartMate II ventricular assist device.
Results showed that patients were less likely to exhibit disease progression, or die, following treatment with beta-emitted microspheres.